EUVIMEDEUVIMED entdecken
Crossref

Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights

Sebastian Ortiz iD, Chiara Bagliani iD, Susan X N Lin iD, Ali S Kusay iD, Katri Silvennoinen iD, Reetta Kälviäinen iD, Leena Jutila iD, Anni Saarela iD, Rebekka S Dahl iD, Tommy Stödberg iD, Carla Marini iD, Elisabetta Cesaroni iD und 17 weitere

Epilepsia · 2026

DOI: 10.1111/epi.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Sebastian Ortiz und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of European Reference Network EpiCARE, Dianalund, Denmark. Hauptthemen laut MEDLINE: Epilepsy, Gain of Function Mutation, Receptors, GABA-A, Neurodevelopmental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Variants in GABRG2 , encoding the γ2 subunit of the γ‐aminobutyric acid type A receptor, are linked to epilepsy phenotypes of varying severity, with gain‐of‐function (GoF) variants associated with the more severe phenotypes than loss‐of‐function variants. Here, we provide a comprehensive analysis of the early clinical features, motor, language, and eating abilities, and structural consequences of the recurrent GABRG2 p.(Ala106Thr) GoF variant, aiming to refine genotype–phenotype correlations and deepen the understanding of GoF‐associated GABRG2 disorders.

Methods

Individuals were recruited through international collaborations, literature review, and patient advocacy groups. Clinical data were collected via standardized interviews and physician reports. Functional effects were assessed using electrophysiological recordings. Structural modeling was performed using homology‐based approaches to evaluate conformational changes.

Results

We collected 23 unrelated individuals harboring the GABRG2 p.(Ala106Thr) variant. Symptoms began with early dysphagia (median onset age = 1 month), hypotonia, seizures (median onset age = 2 months), and hyperkinetic movement disorders (median onset age = 3 months). Epilepsy was present in 91% of the individuals, 71% featuring a developmental and epileptic encephalopathy; 33% of the individuals with epilepsy achieved seizure freedom during the follow‐up. All individuals exhibited moderate to severe cognitive/neurodevelopmental impairment, with profound deficits in motor, language, and other domains. Functional analysis confirmed a GoF effect of the p.(Ala106Thr) variant. By contrast, another variant affecting the same residue, p.(Ala106Pro), which is observed in population databases, was functionally characterized as neutral. Structural modeling indicated that the p.(Ala106Thr) variant may enhance receptor gating by facilitating a hydrogen bond between the extracellular and transmembrane domains, a mechanism not observed with the p.(Ala106Pro) variant. Significance Although some individuals exhibited severe developmental impairment without epilepsy, our findings demonstrate that the recurrent GABRG2 p.(Ala106Thr) GoF variant is consistently associated with a severe neurodevelopmental phenotype. Despite its profound clinical impact, in silico tools consistently predict this variant as benign, highlighting a critical gap in current predictive models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyGain of Function MutationReceptors, GABA-ANeurodevelopmental DisordersPhenotypeGenetic Association StudiesLatent Class AnalysisSymptom BurdenDenmarkHumansMaleFemaleInfant, NewbornInfantChild, PreschoolChildAdolescentYoung AdultAdultFollow-Up Studies

Stichwörter der Autor:innen

GABAA receptorearly onset symptomsfunctional analysisgenotype–phenotype correlation

Substanzen

GABRG2 protein, humanReceptors, GABA-A

Autor:innen und Institutionen

  • Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of European Reference Network EpiCARE, Dianalund, Denmark.
  • Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Instituto Roosevelt, Bogotá, Colombia.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, member of European Reference Network EpiCARE, Genoa, Italy.
  • Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Sebastian Ortiz, Chiara Bagliani, Susan X N Lin, Ali S Kusay, Katri Silvennoinen, Reetta Kälviäinen, Leena Jutila, Anni Saarela, Rebekka S Dahl, Tommy Stödberg, Carla Marini, Elisabetta Cesaroni, Francesca Bisulli, Laura Licchetta, Elisa Fallica, Tommaso Lo Barco, Valentina Rizzo, Felipe Castro-Villablanca, Megan Yabumoto, Ghayda Mirzaa, Alessandra Rossi, Christian Laugaard-Jacobsen, Lino Nobili, Sara I Liin, Elena Gardella, Philip K Ahring, Rikke S Møller, Guido Rubboli

Förderung

  • Lundbeck Foundation

Zitieren

APA

Ortiz, S., Bagliani, C., Lin, S. X. N., Kusay, A. S., Silvennoinen, K., Kälviäinen, R., Jutila, L., Saarela, A., Dahl, R. S., Stödberg, T., Marini, C., Cesaroni, E., Bisulli, F., Licchetta, L., Fallica, E., Barco, T. L., Torta, F., Rizzo, V., Castro-Villablanca, F., …, & Rubboli, G. (2026). Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights. Epilepsia. https://doi.org/10.1111/epi.70045

Vancouver

Ortiz S, Bagliani C, Lin SXN, Kusay AS, Silvennoinen K, Kälviäinen R, et al. Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights. Epilepsia. 2026. doi:10.1111/epi.70045

BibTeX
@article{Ortiz2026,
  author = {Ortiz, Sebastian and Bagliani, Chiara and Lin, Susan X N and Kusay, Ali S and Silvennoinen, Katri and Kälviäinen, Reetta and Jutila, Leena and Saarela, Anni and Dahl, Rebekka S and Stödberg, Tommy and Marini, Carla and Cesaroni, Elisabetta and Bisulli, Francesca and Licchetta, Laura and Fallica, Elisa and Barco, Tommaso Lo and Torta, Francesca and Rizzo, Valentina and Castro-Villablanca, Felipe and Yabumoto, Megan and Mirzaa, Ghayda and Rossi, Alessandra and Laugaard-Jacobsen, Christian and Nobili, Lino and Liin, Sara I and Gardella, Elena and Ahring, Philip K and Møller, Rikke S and Rubboli, Guido},
  title = {Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1111/epi.70045}
}
Kostenlos starten →